Monteverde & Associates PC, a class action law firm, has launched an investigation into Esperion Therapeutics, Inc.'s proposed sale to ARCHIMED-managed funds. The deal offers Esperion shareholders $3.16 per share in cash plus potential milestone payments. The investigation aims to determine if the transaction terms are fair to shareholders. Investors holding Esperion stock are encouraged to seek more information or legal advice from the firm at no cost or obligation.
Red Cat Holdings shares increased by 4.83% in premarket trading following the launch of Hellcat, a new small unmanned aircraft system designed for versatile mission needs. Built on a modular platform, Hellcat supports customizable command, payloads, ...
Skanska has secured a SEK 4.4 billion contract to construct a new emergency hospital building at Karlstad Central Hospital in Sweden. The high-tech, seven-story building will cover approximately 90,000 square meters and include an emergency departmen...
High Tide Inc. has obtained credit approval for C$40 million in senior secured credit facilities from Bank of Montreal. The new loan agreement includes a $25 million revolving facility and a $15 million delayed draw term loan, which will refinance ex...
Gilat Satellite Networks announced it will acquire Comtech Telecommunications' Satellite & Space Communications segment for $157.5 million in cash. This acquisition will create a company with projected annual revenue exceeding $700 million, more than...
Tower Semiconductor announced a multi-year agreement with IQE plc to supply Indium Phosphide (InP) epiwafers, enhancing its silicon photonics capabilities crucial for AI-driven data centers. This deal includes minimum purchase commitments and recipro...
